Log In
C&EN congratulates Dan Fagin on winning the 2014 Pulitzer Prize in General Nonfiction for “Toms River: A Story of Science and Salvation” (Bantam Books). C&EN’s Rudy Baum reviewed “Toms River” last May.
Copyright © 2009 American Chemical Society
November 9, 2009 Cover
Volume 87, Issue 45
Volume 87, Issue 45
NEGLECTED DISEASES
Drug companies and nonprofits are taking novel approaches to refill the pipeline of new drugs and vaccines for neglected diseases
Credit: Newscom
» Full Article
November 9, 2009 Issue
Volume 87, Issue 45
November 9, 2009 Issue, Vol. 87 | Iss. 45
Drug companies and nonprofits are taking novel approaches to refill the pipeline of new drugs and vaccines for neglected diseases
(pp. 16-22)
Features
Government & Policy
News Analysis: Copenhagen meeting is unlikely to produce a new climate-change treaty (pp. 37-39)
Science & Technology
Twenty years after the fall of the Berlin Wall, chemists who lived in former East Germany reflect on science then and now (pp. 42-46)
News of the Week
Old Drugs, New Tricks
Polypharmacology: Ligand-based approach finds new targets of known drugs
(p.11)Clorox To Stop Using Chlorine
Plant Security: Bleach maker will end shipment of hazardous chemical
(p.12)OSHA Hits BP With Record Fine
Safety: $87 million penalty for violations, failure to comply with 2005 settlement
(p.12)Sparking A Sign Of Life
Crystal Growth: Specialized light source drives formation of
optically pure amino acid derivatives
(p.12)Climate-Change Maneuvers
Legislation: Democrats push ahead as Republicans boycott markup meetings
(p.13)Pharma Strategy
Novartis makes major R&D and vaccines investments in China
(p.13)Ironing Out Mercury's Makeup
Planetary Science: New results from spacecraft flyby show iron-rich surface
(p.14)Light Commands Ion Channel
Chemical Biology: Photosensitive reaction opens or shuts potassium's flow
(p.14)Environmental Scrutiny
EPA will assess impacts of black carbon and drilling chemicals for hydraulic fracturing
(p.15)Japanese Earnings Surprise
Fiscal First Half: Firms performed better than feared
(p.15)Departments
Business
Photovoltaic prices will continue to drop, thanks to an oversupply of polysilicon
(pp. 28-30)
Technology management program receives high marks, but not all are pleased
(pp. 32-33)
A visionary in the fine chemicals industry claims a victory in a still-risky business
(p.34)
Drug companies and nonprofits are taking novel approaches to refill the pipeline of new drugs and vaccines for neglected diseases
(pp. 16-22)Concentrates
(pp. 24-25)
(pp. 24-25)- J&J Revamps, Cuts Jobs
- DuPont Forecasts Strong Growth
- Dow Corning Gets Silicon Metal Plants
- Germany’s Merck Leads OLED Group
- ExxonMobil, Toray In Battery Film Venture
- SGL And BMW Form Carbon Fiber Pact
- Mitsui And Sinopec Firm Up China Plans
- Lilly Opens Labs In California
- DSM Shelves China Vitamins Project
- Carbogen Revamps Swiss Operations
- Archimica Makes Changes In Italy
- Takeda Licenses Amylin Obesity Drugs
- Merck Closes On Schering-Plough
- Business Roundup
Government & Policy
News Analysis: Copenhagen meeting is unlikely to produce a new climate-change treaty
(pp. 37-39)
Science & Technology
Twenty years after the fall of the Berlin Wall, chemists who lived in former East Germany reflect on science then and now
(pp. 42-46)
Reluctance to restart production of plutonium-238 could mean the end of deep-space exploration
(p.47)
New software and Websites for the Chemical Enterprise
(p.48)Newscripts
Editor's Page
Most popular
Viewed
Commented
Chemistry Job Listings